]>
IRCT20181205041858N1 IRCT 2019-10-16 Gonabad University of Medical Sciences Comparison The Effect of Ventolin Nebulizer With And Without Hypertonic Saline% 3 On Dyspnea In Patients With Chronic Obstructive Pulmonary Disease Comparison The Effect of Ventolin Nebulizer With And Without Hypertonic Saline % 3 On Dyspnea In Patients With Chronic Obstructive Pulmonary Disease 2019-01-26 anticipated 46 Complete https://irct.ir/trial/35926 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Samples will be divided into two experimental and control groups based on permutation blocks (blocks of size 4). It will be listed according to six possible ways (AABB, ABAB, ...) randomly and the arrangment of receiving intervention will be determined accordingly. For blinding the questionnaire will be completed by a person who is not aware of the research unit in the control group or the experimental group, Blinding description: Participants in research and researcher are aware of the research, but the results evaluator is not aware of the type of intervention. 1-2 Chronic obstructive pulmonary disease. Intervention 1: The intervention group will receive Ventolin plus 5 cc hypertonic saline 3% at intervals of 6 hours as a nebulizer .hypertonic saline 3% at intervals of 6 hours as a nebulizer. Intervention 2: Control group: The control group will receive Ventolin plus 5 cc distilled water at intervals of 6 hours as a nebulizer. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information
public Azam Razizadeh
Gonabad - The Road of the Asian Road - Gonabad University of Medical Sciences
Gonabad Iran (Islamic Republic of) 9691793718 +98 51 5722 5027 razizadeh.a@gmu.ac.ir Gonabad University of Medical Sciences scientific Mehdi Basiri Moghadam
Gonabad - The Road of the Asian Road - Gonabad University of Medical Sciences
Gonabad Iran (Islamic Republic of) 9691793718 +98 51 5722 3028 basiri1344@gmail.com Gonabad University of Medical Sciences Iran (Islamic Republic of) Participate in research. Be alert Be known to be COPD or hospitalized with this diagnosis Have moderate or high dyspnea (at least scale 3 of the bourgeois scale) Nebulizer Ventolin in patient medication orders which have been ordered by a Internal specialist. 19 years no limit Both Patient's death or decreased level of consciousness during treatment After diagnosis, the patient's shortness of breath is due to myocardial infarction, myocardial infarction, or congestive heart failure. Patient's unwillingness to continue research J44.9 Chronic obstructive pulmonary disease, unspecified Treatment - Drugs Placebo The intervention group will receive Ventolin plus 5 cc hypertonic saline 3% at intervals of 6 hours as a nebulizer .hypertonic saline 3% at intervals of 6 hours as a nebulizer. Control group: The control group will receive Ventolin plus 5 cc distilled water at intervals of 6 hours as a nebulizer. Dyspnea. Timepoint: Before and 24, 48 hours after intervention. Method of measurement: Borg scale. Gonabad University of Medical Sciences Approved 2018-12-19 Ethics committee of Gonabad University of Medical Sciences Gonabad University of Medical Sciences, Gonabad Gonabad Razavi Khorasan Iran (Islamic Republic of)